487 related articles for article (PubMed ID: 26210507)
41. Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Petrini B
APMIS; 2006 May; 114(5):319-28. PubMed ID: 16725007
[TBL] [Abstract][Full Text] [Related]
42. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
43. Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
Gonzalo X; Casali N; Broda A; Pardieu C; Drobniewski F
Int J Antimicrob Agents; 2015 Apr; 45(4):406-12. PubMed ID: 25717028
[TBL] [Abstract][Full Text] [Related]
44. Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Pavić K; Perković I; Pospíšilová Š; Machado M; Fontinha D; Prudêncio M; Jampilek J; Coffey A; Endersen L; Rimac H; Zorc B
Eur J Med Chem; 2018 Jan; 143():769-779. PubMed ID: 29220797
[TBL] [Abstract][Full Text] [Related]
45. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Narender M; Jaswanth S B; Umasankar K; Malathi J; Raghuram Reddy A; Umadevi KR; Dusthackeer AVN; Venkat Rao K; Raghuram R A
Bioorg Med Chem Lett; 2016 Feb; 26(3):836-840. PubMed ID: 26755393
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
49. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
50. In vitro antibacterial and antifungal activity of salicylanilide benzoates.
Krátký M; Vinšová J; Buchta V
ScientificWorldJournal; 2012; 2012():290628. PubMed ID: 22666101
[TBL] [Abstract][Full Text] [Related]
51. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
53. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
54. Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Gonzalo X; Drobniewski F
J Antimicrob Chemother; 2013 Feb; 68(2):366-9. PubMed ID: 23070734
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.
Xu S; Li D; Pei L; Yao H; Wang C; Cai H; Yao H; Wu X; Xu J
Bioorg Med Chem Lett; 2014 Jul; 24(13):2811-4. PubMed ID: 24835198
[TBL] [Abstract][Full Text] [Related]
56. Investigation of the antimycobacterial activity of 8-hydroxyquinolines.
Cieslik W; Spaczynska E; Malarz K; Tabak D; Nevin E; O'Mahony J; Coffey A; Mrozek-Wilczkiewicz A; Jampilek J; Musiol R
Med Chem; 2015; 11(8):771-9. PubMed ID: 26256587
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
Claes P; Cappoen D; Mbala BM; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
Eur J Med Chem; 2013 Sep; 67():98-110. PubMed ID: 23850570
[TBL] [Abstract][Full Text] [Related]
58. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
[TBL] [Abstract][Full Text] [Related]
59. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.
Krátký M; Vinšová J; Buchta V
Med Chem; 2012 Jul; 8(4):732-41. PubMed ID: 22548336
[TBL] [Abstract][Full Text] [Related]
60. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates.
Gupta R; Thakur B; Singh P; Singh HB; Sharma VD; Katoch VM; Chauhan SV
Indian J Med Res; 2010 Jun; 131():809-13. PubMed ID: 20571171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]